Carver College of Medicine News: UI team is developing new delivery tools for gene editing
protein delivery to mouse airways using S10 peptide


Carver College of Medicine News: McCray leads grant to improve and advance genome editing


Paul McCray, MD
Dr. McCray was elected to membership in the American Academy of Microbiology

Long-term correction of hemophilia A mice following lentiviral mediated delivery of an optimized canine factor VIII gene
Gene Therapy, September 14, 2017.

Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice.
Proceedings of the national Academy of Sciences. March 27, 2017

Gene therapy for cystic fibrosis lung disease
Jennifer Brown | Sept. 26, 2016
The McCray, Sinn and Zabner labs reported results from two new studies suggesting that gene therapy may be a viable approach for treating or preventing lung disease caused by cystic fibrosis (CF).

Dr. McCray Wins Regents Award for Faculty Excellence
April 27, 2016
One of Iowa’s highest honors for faculty achievement, the award honors faculty members for work representing a significant contribution to excellence in public education.

UI cystic fibrosis researchers receive $11 million
grant renewal for gene therapy work

Medical Student Research Day, Sept. 4, 2015
Outstanding Presentation in Pediatric Basic Science Research 
Rachel Schenkel, M1 
“The LPO/DUOX/Halide Airway Host Defense System Has Antiviral Properties Against Influenza A” 

M.S. Thesis Defense
Abigail Berkebile, Microbiology 
"Airway Surface Liquid Antiviral Activity in Cystic Fibrosis."

Bartlett JA, Meyerholz DK, Wohlford-Lenane CL, Naumann PW, Salzman NH, McCray PB Jr.
“Increased susceptibility to otitis media in a Splunc1-deficient mouse model." Dis Model Mech. 2015 May;8(5):501-8. doi: 10.1242/dmm.019646. Epub 2015 Mar 12. PMID: 25765466